Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Isabel Valero García"'
Autor:
David Aguilera-Alonso, Rocío López Ruiz, Jose Centeno Rubiano, Marta Morell García, Isabel Valero García, María Dolores Ocete Mochón, Elena Montesinos Sanchis
Publikováno v:
Anales de Pediatría, Vol 91, Iss 1, Pp 21-29 (2019)
Resumen: Introducción y objetivos: Mycoplasma pneumoniae (MP) es uno de los agentes etiológicos más comunes de las neumonías adquiridas en la comunidad (NAC) en niños. Objetivo: describir las características clínicas y epidemiológicas, tratam
Externí odkaz:
https://doaj.org/article/85ed233c7bd6483787617d396b7ab833
Autor:
David Aguilera-Alonso, Rocío López Ruiz, Jose Centeno Rubiano, Marta Morell García, Isabel Valero García, María Dolores Ocete Mochón, Elena Montesinos Sanchis
Publikováno v:
Anales de Pediatría (English Edition), Vol 91, Iss 1, Pp 21-29 (2019)
Introduction and objectives: Mycoplasma pneumoniae (MP) is one of the most common etiological agents of community-acquired pneumonia (CAP) in children. We aimed to describe the clinical and epidemiological characteristics, treatment and outcome of ch
Externí odkaz:
https://doaj.org/article/8d1d3ab60ccf4f05ad4254594c68fe5b
Autor:
María del Remedio Guna Serrano, María Rosario Ovies, Enrique Ruiz de Gopegui Bordes, Isabel Valero García, Marta Poveda, Nieves Orta Mira, Concepción Gimeno Cardona
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 38:45-52
Resumen Se presenta el analisis anual de los resultados remitidos durante el ano 2017 por los participantes inscritos en el Programa de Control de Calidad de la Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC), que incluy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::107ed913ee72711ba2148b18b3fe0c2f
https://doi.org/10.1016/j.eimc.2020.02.008
https://doi.org/10.1016/j.eimc.2020.02.008
Autor:
María del Remedio Guna Serrano, Enrique Ruiz de Gopegui Bordes, María Rosario Ovies, Concepción Gimeno Cardona, Marta Poveda, Nieves Orta Mira, Isabel Valero García
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 37:1-8
Resumen Se presenta el analisis anual de los resultados remitidos durante el ano 2016 por los participantes inscritos en el Programa de Control de Calidad de la Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC), que incluy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e55a9fdac064d7a8d84a91d478b48efb
https://doi.org/10.1016/s0213-005x(19)30175-2
https://doi.org/10.1016/s0213-005x(19)30175-2
Autor:
Enrique Ruiz de Gopegui, Bordes, Nieves Orta, Mira, María Del Remedio Guna, Serrano, Isabel Valero, García, María Rosario, Ovies, Marta, Poveda, Concepción Gimeno, Cardona
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 38
This article provides an analysis of the results obtained in 2017 by the participants inscribed in the External Quality Control Programme of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), which includes controls for bac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e599f2bf5f75808a3c232046d1876274
https://pubmed.ncbi.nlm.nih.gov/32111365
https://pubmed.ncbi.nlm.nih.gov/32111365
Autor:
Enrique, Ruiz de Gopegui Bordes, Nieves, Orta Mira, María, Del Remedio Guna Serrano, Isabel, Valero García, María, Rosario Ovies, Marta, Poveda, Concepción, Gimeno Cardona
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 37
The External Quality Control Programme of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) includes controls for bacteriology, serology, mycology, parasitology, mycobacteria, virology, molecular microbiology, and genotypic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff5d7995f52631f24b82c95bd6ccb4ac
https://pubmed.ncbi.nlm.nih.gov/31138417
https://pubmed.ncbi.nlm.nih.gov/31138417
Autor:
David, Aguilera-Alonso, Rocío, López Ruiz, Jose, Centeno Rubiano, Marta, Morell García, Isabel, Valero García, María Dolores, Ocete Mochón, Elena, Montesinos Sanchis
Publikováno v:
Anales De Pediatria
Medical records of children14 years with CAMP were retrospectively reviewed from January 2010 to December 2015. Patients with radiological evidence of pneumonia and microbiological confirmation of MP (PCR from nasopharyngeal swab and/or serum specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df2e46b5150332c9d200e7c36c1f28ab
https://pubmed.ncbi.nlm.nih.gov/32289046
https://pubmed.ncbi.nlm.nih.gov/32289046
Autor:
Alejandro Jover Botella, Eduardo Climent Grana, Juan Pablo Ordovás Baines, Isabel Valero García
Publikováno v:
Farmacia Hospitalaria. 33:125-133
Dabigatran is the fi rst available oral direct thrombin inhibitor anticoagulant. Absorption of the prodrug, dabigatran etexilate and its conversion to dabigatran is rapid (peak plasma concentrations are reached 4-6 hours following surgery, and a furt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dcbb096304665f178c62b9bf7491532
https://doi.org/10.1016/s1130-6343(09)71154-7
https://doi.org/10.1016/s1130-6343(09)71154-7
Autor:
Isabel Valero García, Alejandro Jover Botella, Eduardo Climent Grana, Juan Pablo Ordovás Baines
Publikováno v:
Farmacia Hospitalaria (English Edition). 33:125-133
Dabigatran is the first available oral direct thrombin inhibitor anticoagulant. Absorption of the prodrug, dabigatran etexilate and its conversion to dabigatran is rapid (peak plasma concentrations are reached 4–6 h following surgery, and a further
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b468ffb74e2b08411ecc1c49e6994928
https://doi.org/10.1016/s2173-5085(09)70078-4
https://doi.org/10.1016/s2173-5085(09)70078-4
Autor:
Juan Pablo, Ordovás Baines, Eduardo, Climent Grana, Alejandro, Jover Botella, Isabel, Valero García
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 33(3)
Dabigatran is the first available oral direct thrombin inhibitor anticoagulant. Absorption of the prodrug, dabigatran etexilate and its conversion to dabigatran is rapid (peak plasma concentrations are reached 4-6 hours following surgery, and a furth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a349087ec8833f2571462393386eb100
https://pubmed.ncbi.nlm.nih.gov/20304372
https://pubmed.ncbi.nlm.nih.gov/20304372